SCHEMBL16626674

SCHEMBL16626674

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(C(F)(F)F)cc3C)ccc12

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 6/20 0.39
KMT2A Q03164 1/20 0.39
CYP3A4 P08684 1/20 0.37
CYP3A5 P20815 1/20 0.37
S1PR1 P21453 1/20 0.37
TSHR P16473 1/20 0.37
CYP11B2 P19099 1/20 0.36
IDE P14735 1/20 0.36
HTR6 P50406 2/20 0.35
CSF1R P07333 1/20 0.35
BRAF P15056 1/20 0.35
TEAD1 P28347 1/20 0.35
YAP1 P46937 1/20 0.35
ABL1 P00519 2/20 0.34
BCR P11274 2/20 0.34
KIT P10721 1/20 0.34
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619426 0.99 NAMPT (0.39) NAMPTKMT2ACYP3A4CYP3A5S1PR1
SCHEMBL16626686 0.93 KMT2A (0.38) NAMPTKMT2ACYP3A4CYP3A5S1PR1
SCHEMBL16626403 0.93 KMT2A (0.38) NAMPTKMT2ACYP3A4CYP3A5S1PR1
Hydrochloric Acid SCHEMBL16619137 0.92 KMT2A (0.38) NAMPTKMT2ACYP3A4CYP3A5S1PR1
SCHEMBL16626431 0.92 NAMPT (0.38) NAMPTKMT2ACYP3A4CYP3A5S1PR1
Hydrochloric Acid SCHEMBL16618660 0.92 KMT2A (0.38) NAMPTKMT2ACYP3A4CYP3A5S1PR1
Hydrochloric Acid SCHEMBL16618827 0.91 NAMPT (0.37) NAMPTKMT2ACYP3A4CYP3A5S1PR1
SCHEMBL16626417 0.91 ALDH1A1 (0.40) NAMPTKMT2ATSHRIDEHTR6
SCHEMBL16626423 0.91 CYP19A1 (0.38) NAMPTTSHRIDEHTR6
SCHEMBL16626388 0.91 HTR6 (0.40) NAMPTKMT2ACYP3A4CYP3A5S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI NAMPT 1610/4885KMT2A 3300/4885CYP3A4 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.